Gibbs Wealth Management Astrazeneca PLC Transaction History
Gibbs Wealth Management
- $442 Billion
- Q3 2025
A detailed history of Gibbs Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Gibbs Wealth Management holds 14,444 shares of AZN stock, worth $1.29 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
14,444
Previous 14,591
1.01%
Holding current value
$1.29 Million
Previous $1.02 Billion
8.67%
% of portfolio
0.25%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,478Shares Held
492MCall Options Held
6.18MPut Options Held
3.01M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.38 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.55 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.91 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.88 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.23 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $276B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...